Terms: = Germ cell tumor AND FH, HLRCC, 2271, ENSG00000091483, MCUL1, MCL, LRCC, P07954 AND Prognosis
47 results:
1. Effective Targeting of Melanoma cells by Combination of mcl-1 and Bcl-2/Bcl-x
Peng Z; Gillissen B; Richter A; Sinnberg T; Schlaak MS; Eberle J
Int J Mol Sci; 2024 Mar; 25(6):. PubMed ID: 38542429
[TBL] [Abstract] [Full Text] [Related]
2. tumor Treating Fields (TTFields) combined with the drug repurposing approach CUSP9v3 induce metabolic reprogramming and synergistic anti-glioblastoma activity in vitro.
Cao Q; Hajosch A; Kast RE; Loehmann C; Hlavac M; Fischer-Posovszky P; Strobel H; Westhoff MA; Siegelin MD; Wirtz CR; Halatsch ME; Karpel-Massler G
Br J Cancer; 2024 May; 130(8):1365-1376. PubMed ID: 38396172
[TBL] [Abstract] [Full Text] [Related]
3. Survival Mechanisms of Metastatic Melanoma cells: The Link between Glucocorticoids and the Nrf2-Dependent Antioxidant Defense System.
Obrador E; Salvador-Palmer R; López-Blanch R; Oriol-Caballo M; Moreno-Murciano P; Estrela JM
Cells; 2023 Jan; 12(3):. PubMed ID: 36766760
[TBL] [Abstract] [Full Text] [Related]
4. Pathological prognosis classification of patients with neuroblastoma using computational pathology analysis.
Liu Y; Jia Y; Hou C; Li N; Zhang N; Yan X; Yang L; Guo Y; Chen H; Li J; Hao Y; Liu J
Comput Biol Med; 2022 Oct; 149():105980. PubMed ID: 36001926
[TBL] [Abstract] [Full Text] [Related]
5. Increased apoptotic sensitivity of glioblastoma enables therapeutic targeting by BH3-mimetics.
Koessinger AL; Cloix C; Koessinger D; Heiland DH; Bock FJ; Strathdee K; Kinch K; Martínez-Escardó L; Paul NR; Nixon C; Malviya G; Jackson MR; Campbell KJ; Stevenson K; Davis S; Elmasry Y; Ahmed A; O'Prey J; Ichim G; Schnell O; Stewart W; Blyth K; Ryan KM; Chalmers AJ; Norman JC; Tait SWG
Cell Death Differ; 2022 Oct; 29(10):2089-2104. PubMed ID: 35473984
[TBL] [Abstract] [Full Text] [Related]
6. Pan-Cancer Analysis Reveals FH as a Potential Prognostic and Immunological Biomarker in Lung Adenocarcinoma.
Zhang H; Ju Q; Ji J; Zhao Y
Dis Markers; 2021; 2021():8554844. PubMed ID: 34737838
[TBL] [Abstract] [Full Text] [Related]
7. Stage 4S Neuroblastoma: Molecular, Histologic, and Immunohistochemical Characteristics and Presence of 2 Distinct Patterns of MYCN Protein Overexpression-A Report From the Children's Oncology Group.
Kawano A; Hazard FK; Chiu B; Naranjo A; LaBarre B; London WB; Hogarty MD; Cohn SL; Maris JM; Park JR; Gastier-Foster JM; Ikegaki N; Shimada H
Am J Surg Pathol; 2021 Aug; 45(8):1075-1081. PubMed ID: 33739795
[TBL] [Abstract] [Full Text] [Related]
8. Biological categories of neuroblastoma based on the international neuroblastoma pathology classification for treatment stratification.
Nakazawa A
Pathol Int; 2021 Apr; 71(4):232-244. PubMed ID: 33657257
[TBL] [Abstract] [Full Text] [Related]
9. Cyclin-dependent kinase 12 (CDK12) in chordoma: prognostic and therapeutic value.
Thanindratarn P; Dean DC; Feng W; Wei R; Nelson SD; Hornicek FJ; Duan Z
Eur Spine J; 2020 Dec; 29(12):3214-3228. PubMed ID: 32691223
[TBL] [Abstract] [Full Text] [Related]
10. Aspirin Induced Glioma Apoptosis through Noxa Upregulation.
Chang CY; Pan PH; Li JR; Ou YC; Wang JD; Liao SL; Chen WY; Wang WY; Chen CJ
Int J Mol Sci; 2020 Jun; 21(12):. PubMed ID: 32545774
[TBL] [Abstract] [Full Text] [Related]
11. Ancestry-specific predisposing germline variants in cancer.
Oak N; Cherniack AD; Mashl RJ; ; Hirsch FR; Ding L; Beroukhim R; Gümüş ZH; Plon SE; Huang KL
Genome Med; 2020 May; 12(1):51. PubMed ID: 32471518
[TBL] [Abstract] [Full Text] [Related]
12. A direct comparison of selective BH3-mimetics reveals BCL-X
Bierbrauer A; Jacob M; Vogler M; Fulda S
Br J Cancer; 2020 May; 122(10):1544-1551. PubMed ID: 32203216
[TBL] [Abstract] [Full Text] [Related]
13. Endoplasmic Reticulum Stress Contributes to Indomethacin-Induced Glioma Apoptosis.
Chang CY; Li JR; Wu CC; Wang JD; Liao SL; Chen WY; Wang WY; Chen CJ
Int J Mol Sci; 2020 Jan; 21(2):. PubMed ID: 31952288
[TBL] [Abstract] [Full Text] [Related]
14. mcl-1 Inhibitor Induces cells Death in BRAF-Mutant Amelanotic Melanoma Trough GSH Depletion, DNA Damage and cell Cycle Changes.
Respondek M; Beberok A; Rzepka Z; Rok J; Wrześniok D
Pathol Oncol Res; 2020 Jul; 26(3):1465-1474. PubMed ID: 31432325
[TBL] [Abstract] [Full Text] [Related]
15. Fumaratehydratase-deficient renal cell carcinoma: a clinicopathological and molecular study of 13 cases.
Pan X; Zhang M; Yao J; Zeng H; Nie L; Gong J; Chen X; Xu M; Zhou Q; Chen N
J Clin Pathol; 2019 Nov; 72(11):748-754. PubMed ID: 31262952
[TBL] [Abstract] [Full Text] [Related]
16. Telomerase Activation and ATRX Mutations Are Independent Risk Factors for Metastatic Pheochromocytoma and Paraganglioma.
Job S; Draskovic I; Burnichon N; Buffet A; Cros J; Lépine C; Venisse A; Robidel E; Verkarre V; Meatchi T; Sibony M; Amar L; Bertherat J; de Reyniès A; Londoño-Vallejo A; Favier J; Castro-Vega LJ; Gimenez-Roqueplo AP
Clin Cancer Res; 2019 Jan; 25(2):760-770. PubMed ID: 30301828
[TBL] [Abstract] [Full Text] [Related]
17. Targeting intrinsic apoptosis and other forms of cell death by BH3-mimetics in glioblastoma.
Karpel-Massler G; Ishida CT; Zhang Y; Halatsch ME; Westhoff MA; Siegelin MD
Expert Opin Drug Discov; 2017 Oct; 12(10):1031-1040. PubMed ID: 28712306
[TBL] [Abstract] [Full Text] [Related]
18. UMI-77 primes glioma cells for TRAIL-induced apoptosis by unsequestering Bim and Bak from mcl-1.
Liu JW; Zhu ZC; Li K; Wang HT; Xiong ZQ; Zheng J
Mol Cell Biochem; 2017 Aug; 432(1-2):55-65. PubMed ID: 28337703
[TBL] [Abstract] [Full Text] [Related]
19. TRAIL induces pro-apoptotic crosstalk between the TRAIL-receptor signaling pathway and TrkAIII in SH-SY5Y cells, unveiling a potential therapeutic "Achilles heel" for the TrkAIII oncoprotein in neuroblastoma.
Gneo L; Ruggeri P; Cappabianca L; Farina AR; Di Ianni N; Mackay AR
Oncotarget; 2016 Dec; 7(49):80820-80841. PubMed ID: 27821809
[TBL] [Abstract] [Full Text] [Related]
20. Dinaciclib, a Cyclin-Dependent Kinase Inhibitor Promotes Proteasomal Degradation of mcl-1 and Enhances ABT-737-Mediated cell Death in Malignant Human Glioma cell Lines.
Jane EP; Premkumar DR; Cavaleri JM; Sutera PA; Rajasekar T; Pollack IF
J Pharmacol Exp Ther; 2016 Feb; 356(2):354-65. PubMed ID: 26585571
[TBL] [Abstract] [Full Text] [Related]
[Next]
